Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

W.W. Grainger (GWW) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for W.W. Grainger (GWW) over the last 17 years, with Q3 2025 value amounting to $535.0 million.

  • W.W. Grainger's Cash & Equivalents fell 6305.25% to $535.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $535.0 million, marking a year-over-year decrease of 6305.25%. This contributed to the annual value of $1.0 billion for FY2024, which is 5696.97% up from last year.
  • W.W. Grainger's Cash & Equivalents amounted to $535.0 million in Q3 2025, which was down 6305.25% from $597.0 million recorded in Q2 2025.
  • W.W. Grainger's 5-year Cash & Equivalents high stood at $1.4 billion for Q3 2024, and its period low was $241.0 million during Q4 2021.
  • Moreover, its 5-year median value for Cash & Equivalents was $547.0 million (2021), whereas its average is $580.8 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first crashed by 6587.65% in 2021, then soared by 14093.18% in 2024.
  • Quarter analysis of 5 years shows W.W. Grainger's Cash & Equivalents stood at $241.0 million in 2021, then soared by 34.85% to $325.0 million in 2022, then skyrocketed by 103.08% to $660.0 million in 2023, then soared by 56.97% to $1.0 billion in 2024, then crashed by 48.36% to $535.0 million in 2025.
  • Its Cash & Equivalents stands at $535.0 million for Q3 2025, versus $597.0 million for Q2 2025 and $666.0 million for Q1 2025.